LOS ANGELES, CA – February 18, 2026 (NEWMEDIAWIRE) – LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical and med-tech company…
Read More

LOS ANGELES, CA – February 18, 2026 (NEWMEDIAWIRE) – LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical and med-tech company…
Read More